STADA

Press Releases

Press Releases

STADA Successfully Settles the Placement of 2nd Tranche of Capital Increase

1,869,171 common shares of STADA Arzneimittel AG of the second tranche of the capital increase resolved on 22 September 2003 were successfully placed with investors in a public offer in Germany and a private placement in other member states of the EU, in Switzerland and in the United States of America (in reliance on Rule 144A of the US Securities Act 1933).

The allotment of the placement, which was several times oversubscribed, took place at a price of EUR 46.25 per STADA common share. Further, 186,911 shares of the over-allotment option granted to the Consortium Banks (the so-called "Greenshoe") were alloted. In exercising the Greenshoe the proceeds of the second tranche of the capital increase amount to approximately EUR 86 million. In total, the gross proceeds of the tranche 1 and 2 for STADA amount to approximately EUR 273 million.

STADA CFO Wolfgang Jeblonski expressed satisfaction with respect to the settlement of the placement: "After the successful implementation of the first tranche, we were able to fully realize the planned proceeds of the placement of the second tranche and expand our shareholders' structure. Therefore we have reached all targets of the capital measure."

For more information, please contact:

STADA Arzneimittel AG
Corporate Communications
D-61118 Bad Vilbel
Tel.: +49 6101 603-113
Fax: +49 6101 603-506
e-mail: communications@stada.de

Career at STADA

Career at STADA

STADA's employees, with their extensive expertise, their experience and their strong commitment, play an important part in the longstanding success of the Group.

Learn more

Investor Relations

Investor Relations

Here you can find all the facts and background information about the STADA securities.

Learn more

Sustainability

Sustainability

For STADA "All the best" means taking responsibility.

Learn more

entdecken